camonsertib,Niraparib,Olaparib,Talazoparib
repare therapeutics,roche,gsk,astrazeneca,merck,pfizer
['tresr', 'camonsertib', 'repare therap', 'repare,(-prepare)']
$rptx repare therapeutics presents initial clinical data from the phase 1/2 tresr and attacc trials evaluating camonsertib in combination with three parp inhibitors at the 2023 aacr annual meeting 
This is an automated account sharing new press releases in real time from https://t.co/7iCFuj68H6